NCT06756126View on ClinicalTrials.gov

A Clinical Study of AK120 in Adolescents With Moderate-to-severe Atopic Dermatitis (AD)

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

December 30, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions
Atopic Dermatitis
Interventions
DRUG

AK120

AK120 subcutaneous injection

Trial Locations (6)

Unknown

Dongguan People's Hospital, Dongguan

The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou

The University of Hong Kong - Shenzhen Hospital, Shenzhen

Hunan Pediatric Medical Union, Changsha

Xiangya Hospital Central South University, Changsha

Ning Bo No.2 Hospital, Ningbo

Sponsors

Lead Sponsor

Akeso
All Listed Sponsors
lead

Akeso

INDUSTRY

NCT06756126 - A Clinical Study of AK120 in Adolescents With Moderate-to-severe Atopic Dermatitis (AD) | Biotech Hunter | Biotech Hunter